Work

Muci specific IGE to modify myeloid derived cells of the tumor microenvironment

Year: 2013

Type: article

Abstract: Meeting abstracts We have used antibody (MAb) specific to hypoglycosylated tumor associated MUC1 as a strategy to induce tumor specific immunity. Xenotypic IgG1κ has been previously shown to induce T cell immunity targeting MUC1 in patients. We now describe MUC1 specific IgE to reprogram myeloid

Source: Journal for ImmunoTherapy of Cancer

DOI: 10.1186/2051-1426-1-s1-p245

Authors: J Mollick, M Madiyalakan, C Nicodemus

Institutions: Stanford University, QPS (United States)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,490